Reported Research Benefits Selective GHS-R1a agonism without ACTH, cortisol, or prolactin elevation confirmed in human pharmacology studies Pulsatile GH release: preserves natural GH secretion rhythm (unlike continuous exogenous HGH) Stacked with CJC-1295 DAC: Teichman 2006 showed 210 GH elevation sustained for 911 days Improved body composition: lean mass gain, fat mass reduction in GH secretagogue literature Sleep quality improvement: GH secretion peaks during slow-wave sleep, enhanced by ipamorelin protocols Shorter half-life (~2 hours) allows dosing flexibility and rapid clearance vs long-acting alternatives Dosing Protocol & Reconstitution Reported Research Dosing Not Clinical Recommendations Ipamorelin is most commonly dosed alongside CJC-1295 because the two peptides hit independent receptors (ghrelin and GHRH) and their GH-releasing effects add together
Watch for Signs of Dehydration Semaglutide can slow stomach emptying, which might lead to nausea or vomiting
Pre-existing conditions such as obesity, cardiovascular disease, and clotting disorders can put patients taking Ozempic at a higher risk of developing blood clots
Bannerjee for statistical support
Results still occur but may be in the lower range of expected outcomes
Conklin DJ, Haberzettl P, Prough RA, Bhatnagar A: Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke